FOI 7274 - Breast Cancer Treatment

Date: 26 April 2022 to 26 April 2025

Q1. In the past 3 months (or the latest 3 months data you have available), how many Metastatic/advanced Breast cancer patients were treated with:

 

 

 

  • Abemaciclib (Verzenios) + aromatase inhibitor *

 

  • Abemaciclib (Verzenios) + Fulvestrant (Faslodex)

 

  •   Alpelisib (Piqray) + Fulvestrant (Faslodex)

 

  • Atezolizumab (Tecentriq)**

 

  • Bevacizumab (Avastin)

 

  • Eribulin (Halaven)

 

  • Everolimus (Afinitor) + Exemestane

 

  • Fulvestrant (Faslodex) as a single agent

 

  • Gemcitabine + paclitaxel

 

  • Herceptin (Trastuzumab) + paclitaxel

 

  • Herceptin (Trastuzumab) as a single agent

 

  • Lapatinib (Tyverb)

 

  • Neratinib (Nerlynx)

 

  • Olaparib (Lynparza)

 

  • Palbociclib (Ibrance) + aromatase inhibitor*

 

  • Palbociclib (Ibrance) + Fulvestrant (Faslodex)

 

  • Pertuzumab (Perjeta) + trastuzumab + docetaxel

 

  • Ribociclib (Kisqali) + aromatase inhibitor*

 

  • Ribociclib (Kisqali) + Fulvestrant (Faslodex)

 

  • Talazoparib (Talzenna)

 

  • Trastuzumab emtansine (Kadcyla)

 

  • Other active systemic anti-cancer therapy **

 

*aromatase inhibitor eg. Anastrozole, Exemestane or Letrozole

 

**eg. docetaxel, vinorelbine or capecitabine as a single agent

 

 

 

Q2. For the above patients, how many of these received their first ever dose for each product line?

  • Request ID:
    7274
  • Category:
    Clinical - Drugs
  • Response:

    April 2022

    Q1. In the past 3 months (or the latest 3 months data you have available), how many Metastatic/advanced Breast cancer patients were treated with:

    • Abemaciclib (Verzenios) + aromatase inhibitor *
    • Abemaciclib (Verzenios) + Fulvestrant (Faslodex)
    •   Alpelisib (Piqray) + Fulvestrant (Faslodex)
    • Atezolizumab (Tecentriq)**
    • Bevacizumab (Avastin)
    • Eribulin (Halaven)
    • Everolimus (Afinitor) + Exemestane
    • Fulvestrant (Faslodex) as a single agent
    • Gemcitabine + paclitaxel
    • Herceptin (Trastuzumab) + paclitaxel
    • Herceptin (Trastuzumab) as a single agent
    • Lapatinib (Tyverb)
    • Neratinib (Nerlynx)
    • Olaparib (Lynparza)
    • Palbociclib (Ibrance) + aromatase inhibitor*
    • Palbociclib (Ibrance) + Fulvestrant (Faslodex)
    • Pertuzumab (Perjeta) + trastuzumab + docetaxel
    • Ribociclib (Kisqali) + aromatase inhibitor*
    • Ribociclib (Kisqali) + Fulvestrant (Faslodex)
    • Talazoparib (Talzenna)
    • Trastuzumab emtansine (Kadcyla)
    • Other active systemic anti-cancer therapy **

     

    *aromatase inhibitor eg. Anastrozole, Exemestane or Letrozole

     

    **eg. docetaxel, vinorelbine or capecitabine as a single agent

     

    *Please see below.

     

    Q2. For the above patients, how many of these received their first ever dose for each product line?

    The Trust regret this data is not collated.

     

    *Medway NHS Foundation Trust regret that we are unable to answer this question.  This is because the Trust’s Pharmacy department can provide data on the number of patients that were issued each drug, but their records do not show the indication that each drug was prescribed for.    Please see below pharmacy data for the reporting period 01/01/2022 to 31/03/2022 for the BNF Category: Immune System & Malignant Disease (Chapter 8).  Please note, that if the drug is not listed, it is because it has not been issued.  Where the number is less than five, this has been marked as <5.

     

    Drug Name

    Total Number of Patients

    CALCIUM FOLINATE (ORAL)

    <5

    ABEMACICLIB (VERZENIOS)

    <5

    ABIRATERONE

    18

    ABIRATERONE (ZYTIGA) - HOMECARE

    7

    ACALABRUTINIB (CALQUENCE)

    <5

    ACALABRUTINIB (CALQUENCE) - HOMECARE

    14

    AFATINIB (ORAL)

    <5

    ALECTINIB

    <5

    ANASTROZOLE (ORAL)

    <5

    APALUTIMIDE (ERLEADA)

    <5

    ATEZOLIZUMAB (TECENTRIQ)

    13

    AVELUMAB (BAVENCIO)

    6

    AXITINIB (ORAL)

    7

    AZACITIDINE

    13

    AZATHIOPRINE

    16

    BCG FOR INTRADERMAL USE

    <5

    BCG FOR INTRAVESICAL USE (OncoTICE)

    40

    BENDAMUSTINE

    <5

    BICALUTAMIDE

    24

    BLEOMYCIN

    <5

    BORTEZOMIB

    20

    BOSUTINIB (BOSULIF) - HOMECARE

    6

    BRENTUXIMAB

    <5

    CABAZITAXEL

    <5

    CABOZANTINIB

    <5

    CABOZANTINIB (CABOMETYX)

    <5

    CALCIUM FOLINATE (IV)

    53

    CAPECITABINE (ORAL)

    47

    CARBOPLATIN (IV)

    61

    CARFILZOMIB

    <5

    CETUXIMAB

    7

    CHLORAMBUCIL

    <5

    CICLOSPORIN (DEXIMUNE)

    <5

    CICLOSPORIN (NEORAL)

    <5

    CISPLATIN (IV)

    7

    CYCLOPHOSPHAMIDE (IV)

    83

    CYCLOPHOSPHAMIDE (ORAL)

    6

    CYTARABINE

    6

    DACARBAZINE

    <5

    DARATUMUMAB (DARZALEX)

    11

    DASATINIB

    <5

    DASATINIB (SPRYCEL) - HOMECARE

    6

    DAUNORUBICIN

    <5

    DEXRAZOXANE (SAVENE)

    <5

    DIETHYLSTILBESTROL (STILBOESTROL)

    <5

    DIMETHYL FUMARATE (TECIFIDERA) - HOMECARE

    103

    DIMETHYL SULFOXIDE (DMSO)

    <5

    DOCETAXEL

    30

    DOXORUBICIN

    25

    ENTRECTINIB (ROZLYTREK)

    <5

    ENZALUTAMIDE

    42

    ENZALUTAMIDE (XTANDI) - HOMECARE

    20

    EPIRUBICIN

    52

    ERIBULIN

    <5

    ETOPOSIDE

    15

    EVEROLIMUS

    <5

    EXEMESTANE

    <5

    FLUDARABINE (IV)

    <5

    FLUOROURACIL

    54

    FULVESTRANT

    10

    GEMCITABINE

    14

    GEMTUZUMAB, OZOGAMICIN, MYLOTARG

    <5

    GILTERITINIB (XOSPATA) - HOMECARE

    <5

    GLATIRAMER ACETATE (COPAXONE) - HOMECARE

    8

    HYDROXYCARBAMIDE

    49

    HYDROXYCARBAMIDE - HOMECARE

    <5

    HYDROXYCARBAMIDE (SIKLOS)

    <5

    HYDROXYCARBAMIDE (XROMI)

    <5

    IBRUTINIB

    <5

    IBRUTINIB - HOMECARE

    <5

    IBRUTINIB (IMBRUVICA) - HOMECARE

    13

    IDELALISIB

    <5

    IDELALISIB (ZYDELIG) - HOMECARE

    <5

    IMATINIB

    <5

    IMATINIB - HOMECARE

    7

    INTERFERON BETA 1A (AVONEX) - HOMECARE

    25

    INTERFERON BETA-1a (REBIF via REBISMART) - HOMECARE

    16

    INTERFERON BETA-1b (BETAFERON 250mcg/ml) - HOMECARE

    <5

    IPILIMUMAB (YERVOY)

    <5

    IRINOTECAN

    31

    ISATUXIMAB (SARCLISA)

    <5

    IXAZOMIB (NINLARO)

    <5

    IXAZOMIB (NINLARO) - HOMECARE

    9

    LENALIDAMIDE - HOMECARE

    39

    LENALIDOMIDE

    7

    LETROZOLE

    50

    LETROZOLE - HOMECARE

    <5

    LEUPRORELIN

    <5

    LORLATINIB (LORVIQUA)

    <5

    MELPHALAN

    <5

    MERCAPTOPURINE

    <5

    MESNA

    6

    METHOTREXATE

    <5

    METHOTREXATE (IV)

    <5

    METHOTREXATE (METOJECT PEN)

    16

    METHOTREXATE (METOJECT PEN) - HOMECARE

    209

    METHOTREXATE (ORAL)

    100

    MITOMYCIN

    9

    MYCOPHENOLATE MOFETIL

    16

    MYCOPHENOLIC ACID (ORAL)

    <5

    NATALIZUMAB

    16

    NILOTINIB (TASIGNA) - HOMECARE

    12

    NINTEDANIB

    <5

    NIVOLUMAB (OPDIVO)

    10

    OBINUTUZUMAB

    10

    OCTREOTIDE

    <5

    OSIMERTINIB

    <5

    OXALIPLATIN (IV)

    41

    PACLITAXEL

    60

    PALBOCICLIB

    36

    PALBOCICLIB (IBRANCE) - HOMECARE

    <5

    PANOBINOSTAT

    <5

    PAZOPANIB

    11

    PAZOPANIB (VOTRIENT) - HOMECARE

    <5

    PEMBROLIZUMAB

    39

    PEMETREXTED

    23

    PERTUZUMAB

    <5

    PERTUZUMAB/TRASTUZUMAB (PHESGO)

    39

    POLATUZUMAB (POLIVY)

    <5

    POMALIDOMIDE

    <5

    POMALIDOMIDE (IMNOVID) - HOMECARE

    <5

    PONATINIB - HOMECARE

    <5

    RALTITREXED

    <5

    RASBURICASE

    <5

    RIBOCICLIB

    <5

    RITUXIMAB (MABTHERA)

    13

    RITUXIMAB (RIXATHON)

    7

    RITUXIMAB (TRUXIMA)

    38

    RUXOLITINIB

    <5

    RUXOLITINIB - HOMECARE

    13

    SUNITINIB

    <5

    TACROLIMUS

    <5

    TACROLIMUS (ADOPORT)

    <5

    TACROLIMUS (ADVAGRAF)

    <5

    TACROLIMUS (PROGRAF)

    <5

    TACROLIMUS (TOPICAL)

    <5

    TAMOXIFEN

    12

    TERIFLUNOMIDE (AUBAGIO) - HOMECARE

    42

    THALIDOMIDE

    11

    TIPIRACIL/TRIFLURIDINE

    7

    TOPOTECAN

    <5

    TRASTUZUMAB

    <5

    TRASTUZUMAB (HERCEPTIN)

    18

    TRASTUZUMAB (ONTRUZANT)

    6

    TRASTUZUMAB DERUXTECAN

    10

    TRASTUZUMAB EMTANSINE

    13

    VENETOCLAX

    9

    VENETOCLAX (VENCLYXTO) - HOMECARE

    <5

    VINBLASTINE

    <5

    VINCRISTINE

    38

    VINORELBINE

    10